Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros













Base de datos
Intervalo de año de publicación
1.
Methods Mol Biol ; 1265: 149-59, 2015.
Artículo en Inglés | MEDLINE | ID: mdl-25634274

RESUMEN

For many pathological conditions, reactive oxygen species (ROS) generated in mitochondria are considered to have a role as a trigger. When mitochondrial ROS (mROS) are formed in the inner mitochondrial membrane, they initiate free radical-mediated chain reactions of lipid peroxidation and are thus especially damaging. The consequences of membrane damage are decreased electrical resistance of the membrane, oxidative damage to cardiolipin (a mitochondria specific lipid essential for functioning of respiratory chain proteins and H(+)-ATP synthase), and damage to mitochondrial DNA localized in close vicinity to the inner membrane, with consequent mitochondrial dysfunction and induction of apoptotic cascade and cell death. To target the starting point of such undesirable events, antioxidants conjugated with mitochondria-targeted, membrane-penetrating cations can be used to scavenge ROS inside mitochondria. The most demonstrative indications favoring this conclusion originate from recent discoveries of the in vivo effects of such cations belonging to the MitoQ and SkQ groups. Here we describe some essential methodological aspects of the application of mitochondria-targeted cations promising in treating oxidative stress-related pathologies.


Asunto(s)
Cationes/metabolismo , Mitocondrias/metabolismo , Estrés Oxidativo , Cationes/farmacología , Técnicas de Cultivo de Célula , Permeabilidad de la Membrana Celular , Fluoresceínas/administración & dosificación , Fluoresceínas/química , Peróxido de Hidrógeno/farmacología , Concentración de Iones de Hidrógeno , Membrana Dobles de Lípidos/química , Membrana Dobles de Lípidos/aislamiento & purificación , Liposomas/química , Mitocondrias/efectos de los fármacos , Compuestos Organofosforados/metabolismo , Oxidación-Reducción , Estrés Oxidativo/efectos de los fármacos
2.
Biochim Biophys Acta ; 1797(6-7): 878-89, 2010.
Artículo en Inglés | MEDLINE | ID: mdl-20307489

RESUMEN

The present state of the art in studies on the mechanisms of antioxidant activities of mitochondria-targeted cationic plastoquinone derivatives (SkQs) is reviewed. Our experiments showed that these compounds can operate as antioxidants in two quite different ways, i.e. (i) by preventing peroxidation of cardiolipin [Antonenko et al., Biochemistry (Moscow) 73 (2008) 1273-1287] and (ii) by fatty acid cycling resulting in mild uncoupling that inhibits the formation of reactive oxygen species (ROS) in mitochondrial State 4 [Severin et al. Proc. Natl. Acad. Sci. USA 107 (2009), 663-668]. The quinol and cationic moieties of SkQ are involved in cases (i) and (ii), respectively. In case (i) SkQH2 interrupts propagation of chain reactions involved in peroxidation of unsaturated fatty acid residues in cardiolipin, the formed SkQ- being reduced back to SkQH2 by heme bH of complex III in an antimycin-sensitive way. Molecular dynamics simulation showed that there are two stable conformations of SkQ1 with the quinol residue localized near peroxyl radicals at C9 or C13 of the linoleate residue in cardiolipin. In mechanism (ii), fatty acid cycling mediated by the cationic SkQ moiety is involved. It consists of (a) transmembrane movement of the fatty acid anion/SkQ cation pair and (b) back flows of free SkQ cation and protonated fatty acid. The cycling results in a protonophorous effect that was demonstrated in planar phospholipid membranes and liposomes. In mitochondria, the cycling gives rise to mild uncoupling, thereby decreasing membrane potential and ROS generation coupled to reverse electron transport in the respiratory chain. In yeast cells, dodecyltriphenylphosphonium (capital ES, Cyrillic12TPP), the cationic part of SkQ1, induces uncoupling that is mitochondria-targeted since capital ES, Cyrillic12TPP is specifically accumulated in mitochondria and increases the H+ conductance of their inner membrane. The conductance of the outer cell membrane is not affected by capital ES, Cyrillic12TPP.


Asunto(s)
Antioxidantes/farmacología , Cardiolipinas/metabolismo , Ácidos Grasos/metabolismo , Plastoquinona/análogos & derivados , Animales , Antioxidantes/química , Cardiolipinas/química , Diseño de Fármacos , Humanos , Técnicas In Vitro , Cinética , Mitocondrias/efectos de los fármacos , Mitocondrias/metabolismo , Modelos Biológicos , Simulación de Dinámica Molecular , Oxidación-Reducción , Plastoquinona/química , Plastoquinona/farmacología , Ratas
3.
Proc Natl Acad Sci U S A ; 107(2): 663-8, 2010 Jan 12.
Artículo en Inglés | MEDLINE | ID: mdl-20080732

RESUMEN

A unique phenomenon of mitochondria-targeted protonophores is described. It consists in a transmembrane H(+)-conducting fatty acid cycling mediated by penetrating cations such as 10-(6'-plastoquinonyl)decyltriphenylphosphonium (SkQ1) or dodecyltriphenylphosphonium (C(12)TPP). The phenomenon has been modeled by molecular dynamics and directly proved by experiments on bilayer planar phospholipid membrane, liposomes, isolated mitochondria, and yeast cells. In bilayer planar phospholipid membrane, the concerted action of penetrating cations and fatty acids is found to result in conversion of a pH gradient (DeltapH) to a membrane potential (Deltapsi) of the Nernstian value (about 60 mV Deltapsi at DeltapH = 1). A hydrophobic cation with localized charge (cetyltrimethylammonium) failed to substitute for hydrophobic cations with delocalized charge. In isolated mitochondria, SkQ1 and C(12)TPP, but not cetyltrimethylammonium, potentiated fatty acid-induced (i) uncoupling of respiration and phosphorylation, and (ii) inhibition of H(2)O(2) formation. In intact yeast cells, C(12)TPP stimulated respiration regardless of the extracellular pH value, whereas a nontargeted protonophorous uncoupler (trifluoromethoxycarbonylcyanide phenylhydrazone) stimulated respiration at pH 5 but not at pH 3. Hydrophobic penetrating cations might be promising to treat obesity, senescence, and some kinds of cancer that require mitochondrial hyperpolarization.


Asunto(s)
Cationes/metabolismo , Ácidos Grasos/metabolismo , Mitocondrias/fisiología , Membranas Mitocondriales/fisiología , 1,2-Dipalmitoilfosfatidilcolina/metabolismo , Animales , Carbonil Cianuro p-Trifluorometoxifenil Hidrazona/metabolismo , Senescencia Celular , Citosol/fisiología , Humanos , Concentración de Iones de Hidrógeno , Hipotiroidismo/fisiopatología , Cinética , Mitocondrias Hepáticas/efectos de los fármacos , Mitocondrias Hepáticas/fisiología , Neoplasias/patología , Obesidad/fisiopatología , Compuestos Onio/metabolismo , Compuestos Organofosforados/metabolismo , Plastoquinona/análogos & derivados , Plastoquinona/farmacología , Protones , Ratas , Especies Reactivas de Oxígeno/metabolismo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA